PLXP PLx Pharma Inc.

4.97
+0.01  (+0%)
Previous Close 4.96
Open 4.96
Price To Book -3.36
Market Cap 44,933,727
Shares 9,044,267
Volume 1,877
Short Ratio
Av. Daily Volume 6,789
Stock charts supplied by TradingView

NewsSee all news

  1. PLx Pharma Inc. Presents Moderated Abstract and Simultaneous Publication on the Pharmacokinetic and Pharmacodynamics (PK/PD) Properties of its Novel, Liquid Aspirin Formulation at the 2019 European Society of Cardiology Congress

    SPARTA, N.J. and PARIS, Sept. 03, 2019 (GLOBE NEWSWIRE) -- PLx Pharma Inc. (NASDAQ:PLXP) ("PLx" or the "Company"), a late-stage specialty pharmaceutical company focused on developing more effective and safer products

  2. PLx Pharma Inc. to Present at Janney Healthcare Conference 2019 on September 10

    SPARTA, N.J., Aug. 28, 2019 (GLOBE NEWSWIRE) -- PLx Pharma Inc. (NASDAQ:PLXP) ("PLx" or the "Company"), a late-stage specialty pharmaceutical company initially focused on developing its clinically validated and

Drug Information

Drug catalyst information is displayed when you hover over / tap on the stage bar graph.

Phase 3 top-line data did not meet endpoints - October 25, 2016.
Locilex
Mild infections of diabetic foot ulcers
sNDA filing due late 2019.
Aspertec
Aspirin - cardiovascular and stroke patients patients

Latest News

  1. PLx Pharma Inc. Presents Moderated Abstract and Simultaneous Publication on the Pharmacokinetic and Pharmacodynamics (PK/PD) Properties of its Novel, Liquid Aspirin Formulation at the 2019 European Society of Cardiology Congress

    SPARTA, N.J. and PARIS, Sept. 03, 2019 (GLOBE NEWSWIRE) -- PLx Pharma Inc. (NASDAQ:PLXP) ("PLx" or the "Company"), a late-stage specialty pharmaceutical company focused on developing more effective and safer products

  2. PLx Pharma Inc. to Present at Janney Healthcare Conference 2019 on September 10

    SPARTA, N.J., Aug. 28, 2019 (GLOBE NEWSWIRE) -- PLx Pharma Inc. (NASDAQ:PLXP) ("PLx" or the "Company"), a late-stage specialty pharmaceutical company initially focused on developing its clinically validated and